Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thao P Dang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|March 18, 2004
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domainDmitri V Kravtsov, Wenman Wu, Joost C M Meijers, et al.
The Journal of Physical Chemistry. B|December 3, 2020
Site of Azido Substitution in the Sugar Moiety of Azidopyrimidine Nucleosides Influences the Reactivity of Aminyl Radicals Formed by Dissociative Electron AttachmentMukesh Mudgal, Thao P Dang, Adam J Sobczak, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
The Journal of Physical Chemistry. B|April 21, 2017
Prehydrated One-Electron Attachment to Azido-Modified Pentofuranoses: Aminyl Radical Formation, Rapid H-Atom Transfer, and Subsequent Ring OpeningMukesh Mudgal, Sunny Rishi, Daniel A Lumpuy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimenStuart Salmon, Heidi Chen, Shuo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancerRoy S Herbst, Angela M Davies, Ronald B Natale, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|March 18, 2004
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domainDmitri V Kravtsov, Wenman Wu, Joost C M Meijers, et al.
The Journal of Physical Chemistry. B|December 3, 2020
Site of Azido Substitution in the Sugar Moiety of Azidopyrimidine Nucleosides Influences the Reactivity of Aminyl Radicals Formed by Dissociative Electron AttachmentMukesh Mudgal, Thao P Dang, Adam J Sobczak, et al.
Lung Cancer (Amsterdam, Netherlands)|December 29, 2009
VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumabDavid P Carbone, J Stuart Salmon, Dean Billheimer, et al.
The Journal of Physical Chemistry. B|April 21, 2017
Prehydrated One-Electron Attachment to Azido-Modified Pentofuranoses: Aminyl Radical Formation, Rapid H-Atom Transfer, and Subsequent Ring OpeningMukesh Mudgal, Sunny Rishi, Daniel A Lumpuy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2009
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimenStuart Salmon, Heidi Chen, Shuo Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancerRoy S Herbst, Angela M Davies, Ronald B Natale, et al.
Pageof 2